Quretech.com

Quretech.com has Server used 93.188.2.52 IP Address with Hostname in Sweden. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2013-11-08 (6 years, 249 days) and hosted in Sweden, server ping response time 187 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Quretech keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Quretech
2 Quretech bio
3 Quartech
4 Quiretech
5 Quartech 9304
6 Quartech corp
7 Quartech 2800
8 Quartech canada
9 Quartech display

Hosting Provider

Website: Quretech.com
Hostname: webfront2.webcluster.loopia.se
Country:
Latitude: 59.329399108887
Longitude: 18.068599700928
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Challengescatalyst.com (10 seconds ago)

   » Followerspromotion.com (10 seconds ago)

   » Cashflowready.com (3 seconds ago)

   » Nordicuws.com (17 seconds ago)

   » Petromat.org (14 seconds ago)

   » Ladymarmaladenails.com (4 seconds ago)

   » Derbio.com (24 seconds ago)

   » Medicalhair4u.com (12 seconds ago)

   » Mix-choice.com (14 seconds ago)

   » Driftgreenville.com (4 seconds ago)

Results For Websites Listing

Found 45 Websites with content related to this domain, It is result after search with search engine

Quretech Bio - Defeats bacterial virulence, restores

(9 day ago) QureTech Bio’s vision is to develop first-line drugs to combat infectious diseases and the occurrence of antibiotic resistance. The company was founded in 2010 to commercialize world-leading research from groups based at Umeå University, Sweden, and Washington University, St Louis, USA.

https://quretech.com/

DA: 12 PA: 12 MOZ Rank: 13

QureTech Bio secures US patent - Nordic Life Science – the

(11 day ago) QureTech Bio has received preliminary approval for a patent application in the US for a drug candidate that helps treat tuberculosis. “The US is a key market for us so this news really helps strengthen our position. We are at a very exciting stage right now,” says Fredrik Almqvist, CEO of QureTech Bio.

https://nordiclifescience.org/quretech-bio-secures-us-patent/

DA: 21 PA: 32 MOZ Rank: 53

Quretech Bio - fighting bacterial virulence - UBI

(1 month ago) Quretech Bio develops innovative antibiotics by stopping bacterial virulence with a first-in-class active substance. The approach is not to kill bacteria, but make them harmless - thus complementing existing treatments and making established antibiotic drugs more effective without causing resistance.

https://www.ubi.se/case/quretech-bio-fighting-bacterial-virulence/

DA: 10 PA: 48 MOZ Rank: 58

QureTech Bio awarded 3 million SEK - Nordic Life Science

(7 day ago) QureTech Bio has received a SEK 3 million grant from the Swelife innovation programme, funded by the Swedish Government via Vinnova. “We are delighted to receive this grant, as it will enable us to create a product that can help patients and save lives,” says Fredrik Almqvist, CEO of QureTech Bio.

https://nordiclifescience.org/quretech-bio-awarded-3-million-sek/

DA: 21 PA: 36 MOZ Rank: 57

QURETECH BIO AB

(29 day ago) QURETECH BIO AB Defeats bacterial virulence without affecting the normal bacterial flora Market Need And Potential Antibiotic resistance is a serious and accelerating problem. Infections with multidrug resistant bacteria cause around 25 000 deaths annually in the EU alone, and the accompanying economic burden is immense. Without

http://media.quretech.com/2014/05/QTB-TUb-2016-final.pdf

DA: 18 PA: 31 MOZ Rank: 49

Quretech Bio awarded millions in fight against antibiotic

(3 month ago) Researchers at Quretech Bio are currently working on three parallel projects: one that develops solutions for acute infections caused by antibiotic-resistant bacteria such as MRSA and VRE, one for tuberculosis and one for chlamydia. The company has identified substances that have shown positive effects in difficult to treat disease models.

https://www.epmmagazine.com/news/quretech-bio/

DA: 19 PA: 19 MOZ Rank: 38

Researchers from Quretech Bio AB awarded additional

(1 month ago) Researchers from Quretech Bio AB (Quretech Bio) in Umeå, who were awarded a research grant of approximately SEK 25 million in the summer, have been awarded additional funding of just over SEK 17 million this autumn (made up of SEK 7.5 million from the Swedish Research Council, SEK 8 million from the Erling Persson Family Foundation and SEK 2.1 million from Umeå University).

https://www.ubi.se/news/forskarna-bakom-quretech-bio-erhaller-ytterligare-17-msek-i-anslag/

DA: 10 PA: 50 MOZ Rank: 83

Quretec - Clinical Trial Data Management, Registries

(1 month ago) Qure Platform is well suitable for Clinical Trial Data Management, Health Registries, Biobank databases, Electronic Data Collection. Quretec provides bioinformatics and statistical analysis services.

http://www.quretec.com/

DA: 15 PA: 15 MOZ Rank: 16

Jeep Parts & Accessories for Jeep Wrangler | Quadratec

(7 day ago) Expert Advice on Jeep Accessories. For over 25 years, Quadratec has proudly provided Jeep enthusiasts the best parts and accessories available. Our company was founded on one principle: Provide the highest level of service and top quality products to all our customers - every day.

https://www.quadratec.com/

DA: 17 PA: 17 MOZ Rank: 18

Recently Analyzed Sites